South Carolina: Saxenda litigation | DrugsMonitor.com

Saxenda litigation in South Carolina (SC): MDL-linked practice notes, filing-deadline context, confidential review—not legal advice.

Liraglutide (Saxenda) is a GLP-1-class therapy; plaintiffs group gastrointestinal and related injury theories with broader GLP-1 litigation themes., South Carolina